Literature DB >> 15242683

Functional genetics and experimental models of human cancer.

Jean J Zhao1, Thomas M Roberts, William C Hahn.   

Abstract

Abundant evidence supports the hypothesis that cancer arises from normal cells through the stepwise accumulation of genetic mutations. The study of cells obtained from patients with cancer has identified numerous molecules and pathways that fundamentally contribute to malignant transformation; however, cancer cell lines are often difficult to isolate or maintain, and the cell lines that are available for experimentation represent only a small subset of late-stage human cancers. Recent work has elucidated the role of telomerase in regulating human cell lifespan and has enabled the development of new experimental systems to study human cancer. This review highlights the recent progress in combining genetic methods and primary human cells to understand the role of specific genes and pathways in cancer pathogenesis.

Entities:  

Mesh:

Year:  2004        PMID: 15242683     DOI: 10.1016/j.molmed.2004.05.005

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  19 in total

1.  Identification of PP2A complexes and pathways involved in cell transformation.

Authors:  Anna A Sablina; Melissa Hector; Nathalie Colpaert; William C Hahn
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

Review 2.  Targeting PP2A in cancer: Combination therapies.

Authors:  Sahar Mazhar; Sarah E Taylor; Jaya Sangodkar; Goutham Narla
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-09-01       Impact factor: 4.739

Review 3.  Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology.

Authors:  Chenguang Wang; Michael P Lisanti; D Joshua Liao
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

4.  The oncogenic properties of mutant p110alpha and p110beta phosphatidylinositol 3-kinases in human mammary epithelial cells.

Authors:  Jean J Zhao; Zhenning Liu; Li Wang; Eyoung Shin; Massimo F Loda; Thomas M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-08       Impact factor: 11.205

5.  The HBP1 transcriptional repressor participates in RAS-induced premature senescence.

Authors:  Xiaowei Zhang; Jiyoung Kim; Robin Ruthazer; Michael A McDevitt; David E Wazer; K Eric Paulson; Amy S Yee
Journal:  Mol Cell Biol       Date:  2006-09-11       Impact factor: 4.272

6.  Towards a more functional concept of causality in cancer research.

Authors:  Eiliv Lund; Vanessa Dumeaux
Journal:  Int J Mol Epidemiol Genet       Date:  2010-03-15

7.  PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant glioma.

Authors:  Pietri Puustinen; Melissa R Junttila; Sari Vanhatupa; Anna A Sablina; Melissa E Hector; Kaisa Teittinen; Olayinka Raheem; Kirsi Ketola; Shujun Lin; Juergen Kast; Hannu Haapasalo; William C Hahn; Jukka Westermarck
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

8.  Senescent stromal-derived osteopontin promotes preneoplastic cell growth.

Authors:  Ermira Pazolli; Xianmin Luo; Sarah Brehm; Kelly Carbery; Jun-Jae Chung; Julie L Prior; Jason Doherty; Shadmehr Demehri; Lorena Salavaggione; David Piwnica-Worms; Sheila A Stewart
Journal:  Cancer Res       Date:  2009-01-20       Impact factor: 12.701

Review 9.  Attacking a nexus of the oncogenic circuitry by reversing aberrant eIF4F-mediated translation.

Authors:  Peter B Bitterman; Vitaly A Polunovsky
Journal:  Mol Cancer Ther       Date:  2012-05       Impact factor: 6.261

10.  The tumor suppressor PP2A Abeta regulates the RalA GTPase.

Authors:  Anna A Sablina; Wen Chen; Jason D Arroyo; Laura Corral; Melissa Hector; Sara E Bulmer; James A DeCaprio; William C Hahn
Journal:  Cell       Date:  2007-06-01       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.